Related Content
Search Google Scholar for:
|
|
Science 1 June 1984: Vol. 224. no. 4652, pp. 994 - 996 DOI: 10.1126/science.6372095
|
|
Articles
Science, Vol 224, Issue 4652, 994-996
Copyright © 1984 by American Association for the Advancement of Science
Reversal of adriamycin resistance by verapamil in human ovarian cancer
AM Rogan,
TC Hamilton,
RC Young,
RW Klecker Jr,
and
RF Ozols
The effectiveness of adriamycin in the treatment of ovarian cancer and other human tumors has been limited by the development of drug resistance. Verapamil, a calcium channel blocking agent, completely reversed adriamycin resistance in human ovarian cancer cells with moderate (three- to sixfold) degrees of resistance and partially reversed resistance in highly (150-fold) resistant cells. The potentiating effect of verapamil was due to inhibition of adriamycin efflux in the resistant cells. These results have led to a clinical trial of adriamycin and verapamil in refractory ovarian cancer patients.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- A role for ceramide in driving cancer cell resistance to doxorubicin.
- Y.-Y. Liu, J. Y. Yu, D. Yin, G. A. Patwardhan, V. Gupta, Y. Hirabayashi, W. M. Holleran, A. E. Giuliano, S. M. Jazwinski, V. Gouaze-Andersson, et al. (2008)
FASEB J
22, 2541-2551
| Abstract »
| Full Text »
| PDF »
- Concise Review: Clinical Relevance of Drug Drug and Herb Drug Interactions Mediated by the ABC Transporter ABCB1 (MDR1, P-glycoprotein).
- S. Marchetti, R. Mazzanti, J. H. Beijnen, and J. H. M. Schellens (2007)
Oncologist
12, 927-941
| Abstract »
| Full Text »
| PDF »
- Oligonucleotides blocking glucosylceramide synthase expression selectively reverse drug resistance in cancer cells.
- Y.-Y. Liu, T. Y. Han, J. Y. Yu, A. Bitterman, A. Le, A. E. Giuliano, and M. C. Cabot (2004)
J. Lipid Res.
45, 933-940
| Abstract »
| Full Text »
| PDF »
- Improvement of Oral Drug Treatment by Temporary Inhibition of Drug Transporters and/or Cytochrome P450 in the Gastrointestinal Tract and Liver: An Overview.
- C.M.F. Kruijtzer, J.H. Beijnen, and J.H.M. Schellens (2002)
Oncologist
7, 516-530
| Abstract »
| Full Text »
| PDF »
- Peptide Transport by the Multidrug Resistance Protein MRP1.
- M. C. de Jong, J. W. Slootstra, G. L. Scheffer, A. B. Schroeijers, W. C. Puijk, R. Dinkelberg, M. Kool, H. J. Broxterman, R. H. Meloen, and R. J. Scheper (2001)
Cancer Res.
61, 2552-2557
| Abstract »
| Full Text »
- In Vitro and in Vivo Reversal of P-Glycoprotein-mediated Multidrug Resistance by a Novel Potent Modulator, XR9576.
- P. Mistry, A. J. Stewart, W. Dangerfield, S. Okiji, C. Liddle, D. Bootle, J. A. Plumb, D. Templeton, and P. Charlton (2001)
Cancer Res.
61, 749-758
| Abstract »
| Full Text »
- Cisplatin and Adriamycin Resistance Are Associated with MutLalpha and Mismatch Repair Deficiency in an Ovarian Tumor Cell Line.
- J. T. Drummond, A. Anthoney, R. Brown, and P. Modrich (1996)
J. Biol. Chem.
271, 19645-19648
| Abstract »
| Full Text »
| PDF »
- Accumulation of Glucosylceramides in Multidrug-resistant Cancer Cells.
- Y. Lavie, H.-t. Cao, S. L. Bursten, A. E. Giuliano, and M. C. Cabot (1996)
J. Biol. Chem.
271, 19530-19536
| Abstract »
| Full Text »
| PDF »
- Markedly Decreased Expression of Glutathione S-Transferase [IMAGE] Gene in Human Cancer Cell Lines Resistant to Buthionine Sulfoximine, an Inhibitor of Cellular Glutathione Synthesis.
- A. Yokomizo, K. Kohno, M. Wada, M. Ono, C. S. Morrow, K. H. Cowan, and M. Kuwano (1995)
J. Biol. Chem.
270, 19451-19457
| Abstract »
| Full Text »
| PDF »
- Amplification of a gene related to mammalian mdr genes in drug-resistant Plasmodium falciparum.
- C. Wilson, A. Serrano, A Wasley, M. Bogenschutz, A. Shankar, and D. Wirth (1989)
Science
244, 1184-1186
| Abstract »
| PDF »
- Reversal of chloroquine resistance in Plasmodium falciparum by verapamil.
- S. Martin, A. Oduola, and W. Milhous (1987)
Science
235, 899-901
| Abstract »
| PDF »
- Human multidrug-resistant cell lines: increased mdr1 expression can precede gene amplification.
- D. Shen, A Fojo, J. Chin, I. Roninson, N Richert, I Pastan, and M. Gottesman (1986)
Science
232, 643-645
| Abstract »
| PDF »
|
|